Eventide Healthcare & Life Sciences A (ETAHX) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Eventide Healthcare & Life Sciences A (ETAHX) trades at $58.65. Eventide Healthcare & Life Sciences A is a mutual fund focused on investing in equity and equity-related securities within the healthcare and life sciences… Market cap: $1.95B, Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for ETAHX: ETAHX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ETAHX against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ETAHX: 1/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Eventide Healthcare & Life Sciences A (ETAHX) Financial Services Profile
Eventide Healthcare & Life Sciences A is a financial services firm specializing in healthcare and life sciences sector investments, offering diversified exposure through equity and equity-related securities across various market capitalizations and geographies. It competes with other asset managers in a growing but competitive market.
What Is the Investment Thesis for ETAHX?
Eventide Healthcare & Life Sciences A presents an investment opportunity centered on the growth potential of the healthcare and life sciences sectors. With a beta of 1.27, the fund exhibits higher volatility compared to the broader market. The fund's strategy of investing across various market capitalizations and geographies allows it to capture diverse opportunities within the healthcare and life sciences industries. The absence of a dividend yield may deter income-focused investors, but the fund's focus on capital appreciation could appeal to growth-oriented investors. The fund's performance will be closely tied to the overall health of the healthcare and life sciences sectors, as well as its ability to identify and capitalize on promising investment opportunities.
Based on FMP financials and quantitative analysis
ETAHX Key Highlights
Market capitalization of $1.95B indicates a substantial asset base.
- Beta of 1.27 suggests higher volatility compared to the overall market.
- Investment focus on healthcare and life sciences sectors provides targeted exposure to these industries.
- Flexibility to invest in companies of any market capitalization allows for diversification across the sector.
- Absence of dividend yield may appeal to growth-oriented investors seeking capital appreciation.
Who Are ETAHX's Competitors?
ETAHX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AEMGX Acadian Emerging Markets Investor | $34.50 | +0.47% | $1.87B | — |
| AEMZX Acadian Emerging Markets Portfolio Class I | $34.49 | +0.47% | $1.81B | — |
| AOOIX American Century One Choice 2045 Portfolio - I Class | $19.17 | -0.42% | $1.26B | 44 |
| AROIX American Century One Choice 2045 Portfolio Investor Class | $19.12 | -0.47% | $1.25B | 44 |
| ARWIX American Century One Choice 2025 Portfolio Investor Class | $13.22 | -0.75% | $1.30B | 46 |
| TSLX Sixth Street Specialty Lending, Inc. | $18.77 | +0.37% | $1.78B | 68 |
| CET Central Securities Corp. | $54.21 | -0.90% | $1.60B | 70 |
| GCMG GCM Grosvenor Inc. | $13.47 | -2.25% | $2.52B | 95 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ETAHX's Key Strengths?
Specialized focus on healthcare and life sciences sectors.
- Flexibility to invest in companies of any market capitalization.
- Ability to invest in international companies through ADRs.
- Experienced investment management team.
What Are ETAHX's Weaknesses?
Concentration risk due to focus on a single sector.
- Potential for higher volatility compared to broader market indices.
- Dependence on the performance of the healthcare and life sciences sectors.
- Absence of dividend yield may deter income-focused investors.
What Could Drive ETAHX Stock Higher?
Advancements in biotechnology and pharmaceutical research driving growth in the sector.
- Aging global population increasing demand for healthcare services and products.
- Potential regulatory changes impacting the healthcare and life sciences sectors (e.g., drug pricing reforms).
- Increasing adoption of digital health technologies and telemedicine.
What Are the Key Risks for ETAHX?
Economic downturns affecting healthcare spending and investment.
- Regulatory changes impacting the healthcare and life sciences sectors (e.g., drug pricing reforms).
- Geopolitical risks impacting international investments.
- Competition from other asset managers offering similar products.
- Concentration risk due to focus on a single sector.
What Are the Growth Opportunities for ETAHX?
- Expansion into Emerging Markets: Eventide Healthcare & Life Sciences A can explore growth opportunities by expanding its investments into emerging markets. These markets often exhibit higher growth rates in the healthcare and life sciences sectors due to factors such as increasing healthcare access and rising disposable incomes. By allocating a portion of its portfolio to emerging market companies, the fund can potentially enhance its returns and diversify its geographic exposure. The timeline for this expansion could be phased over the next 3-5 years, starting with a pilot program in select countries.
- Increased Focus on Biotechnology: The biotechnology industry is experiencing rapid innovation and growth, driven by advancements in areas such as gene editing, personalized medicine, and immunotherapy. Eventide Healthcare & Life Sciences A can capitalize on this trend by increasing its allocation to biotechnology companies. This would allow the fund to benefit from the potential for high returns associated with successful drug development and commercialization. A strategic shift towards biotechnology could be implemented within the next 2 years, focusing on companies with promising pipelines and strong intellectual property.
- Development of Thematic Funds: Eventide Healthcare & Life Sciences A can create new thematic funds that focus on specific sub-sectors within healthcare and life sciences, such as genomics, medical devices, or digital health. These thematic funds would cater to investors seeking targeted exposure to these high-growth areas. The launch of thematic funds could be staggered over the next 3 years, starting with the most promising sub-sectors based on market demand and growth potential.
- Strategic Partnerships: Eventide Healthcare & Life Sciences A can form strategic partnerships with other firms in the healthcare and life sciences ecosystem, such as research institutions, pharmaceutical companies, or healthcare providers. These partnerships can provide the fund with access to valuable insights, deal flow, and expertise. Collaborative ventures could be established within the next 1-2 years, focusing on areas such as joint research projects or co-investment opportunities.
- Enhanced Digital Marketing: Eventide Healthcare & Life Sciences A can invest in enhanced digital marketing efforts to increase its visibility and attract new investors. This could include developing a more user-friendly website, creating engaging content, and utilizing social media platforms to reach a wider audience. A comprehensive digital marketing strategy could be implemented within the next year, focusing on targeted campaigns and data-driven optimization.
What Are ETAHX's Competitive Advantages?
- Expertise in healthcare and life sciences sectors.
- Established track record of investment performance.
- Diversified portfolio across various market capitalizations and geographies.
What Does ETAHX Do?
Eventide Healthcare & Life Sciences A is a mutual fund that directs its investments towards the healthcare and life sciences sectors. The fund operates under the principle of allocating at least 80% of its net assets, in addition to any borrowings for investment purposes, into equity and equity-related securities. These securities encompass a range of financial instruments, including common stock, options, preferred stock, and convertible debt. The fund's investment strategy is not confined by geographical boundaries, as it is authorized to invest, without limitation, in securities of companies located outside the United States. These investments can be made either directly or through American Depositary Receipts (ADRs). Eventide Healthcare & Life Sciences A does not restrict its investments based on market capitalization, allowing it to invest in companies of any size, from small-cap to large-cap enterprises. This flexibility enables the fund to capture opportunities across the entire spectrum of the healthcare and life sciences industries, adapting to market dynamics and seeking optimal returns for its investors. The fund's approach reflects a commitment to providing investors with exposure to the growth potential of the healthcare and life sciences sectors, while also maintaining a diversified portfolio to mitigate risk.
What Products and Services Does ETAHX Offer?
- Invests primarily in equity and equity-related securities.
- Focuses on companies within the healthcare and life sciences sectors.
- Invests in companies of any market capitalization.
- May invest in securities of companies domiciled outside the United States.
- Utilizes American Depositary Receipts (ADRs) for international investments.
- Aims to provide investors with exposure to the growth potential of the healthcare and life sciences sectors.
How Does ETAHX Make Money?
- Generates revenue through management fees charged on assets under management (AUM).
- Aims to achieve capital appreciation for investors through strategic investments in healthcare and life sciences companies.
- Seeks to outperform its benchmark index by actively managing its portfolio and identifying promising investment opportunities.
What Industry Does ETAHX Operate In?
Eventide Healthcare & Life Sciences A operates within the asset management industry, specifically focusing on the healthcare and life sciences sectors. The asset management industry is characterized by intense competition, with numerous firms offering a wide range of investment products and services. The healthcare and life sciences sectors are driven by factors such as aging populations, technological advancements, and increasing healthcare spending. These sectors are subject to regulatory scrutiny and are influenced by factors such as drug pricing and healthcare reform. Eventide Healthcare & Life Sciences A competes with other asset managers, such as AEMGX, AEMZX, AOOIX, AROIX, and ARWIX, in attracting investors seeking exposure to the healthcare and life sciences sectors.
Who Are ETAHX's Key Customers?
- Individual investors seeking exposure to the healthcare and life sciences sectors.
- Institutional investors, such as pension funds, endowments, and foundations.
- Financial advisors who recommend the fund to their clients.
How Eventide Healthcare & Life Sciences A Is Valued
Eventide Healthcare & Life Sciences A carries a market capitalization of $1.95B, placing it in the small-cap category.
Key Financial Metrics
Return on equity for Eventide Healthcare & Life Sciences A stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. ETAHX trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
ETAHX Financials
Bull Case vs Bear Case
Bull Case
- Specialized focus on healthcare and life sciences sectors.
- Flexibility to invest in companies of any market capitalization.
- Ability to invest in international companies through ADRs.
- Experienced investment management team.
Bear Case
- Concentration risk due to focus on a single sector.
- Potential for higher volatility compared to broader market indices.
- Dependence on the performance of the healthcare and life sciences sectors.
- Absence of dividend yield may deter income-focused investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
ETAHX Latest News
No recent news available for ETAHX.
ETAHX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ETAHX.
Price Targets
Wall Street price target analysis for ETAHX.
ETAHX MoonshotScore
What does this score mean?
The MoonshotScore rates ETAHX 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
ETAHX Financial Services Stock FAQ
What does Eventide Healthcare & Life Sciences A do?
Eventide Healthcare & Life Sciences A is a mutual fund that invests primarily in equity and equity-related securities of companies within the healthcare and life sciences sectors. The fund's objective is to provide investors with exposure to the growth potential of these sectors, while also maintaining a diversified portfolio to mitigate risk.
What are the main risks for ETAHX?
The main risks for Eventide Healthcare & Life Sciences A include concentration risk due to its focus on a single sector, potential for higher volatility compared to broader market indices, dependence on the performance of the healthcare and life sciences sectors, and regulatory changes impacting these sectors.
How does Eventide Healthcare & Life Sciences A manage sector-specific risks?
Eventide Healthcare & Life Sciences A manages sector-specific risks through diversification within the healthcare and life sciences sectors, investing in companies of various sizes and across different sub-sectors. The fund also conducts in-depth research and analysis to identify companies with strong fundamentals and growth potential.
What regulatory challenges does Eventide Healthcare & Life Sciences A face?
Eventide Healthcare & Life Sciences A faces regulatory challenges related to its investments in the healthcare and life sciences sectors, which are subject to extensive government regulation. These regulations can impact drug pricing, healthcare reimbursement, and product approvals. The fund must also comply with securities regulations and reporting requirements.
What are the key factors to evaluate for ETAHX?
Evaluate ETAHX on fundamentals, analyst consensus, and risk factors. Eventide Healthcare & Life Sciences A presents an investment opportunity centered on the growth potential of the healthcare and life sciences sectors. Not financial advice.
How frequently does ETAHX data refresh on this page?
ETAHX's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven ETAHX's recent stock price performance?
Eventide Healthcare & Life Sciences A (ETAHX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized focus on healthcare and life sciences sectors. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ETAHX overvalued or undervalued right now?
Eventide Healthcare & Life Sciences A (ETAHX) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for ETAHX, limiting comprehensive insights.
- Financial data based on available information as of 2026-03-17.
- Investment decisions should be based on individual risk tolerance and financial goals.